By Diane Alter, Contributing Writer, Money Morning-
The Valeant Pharmaceutical International Inc. (NYSE: VRX) stock price has come under pressure yet again this week following a new downgrade and significantly lowered company guidance.
Late last week, Valeant lowered its Q4 outlook and guided Q1 fiscal 2016 sales and earnings below Wall Street estimates.
By Diane Alter, Contributing Writer, Money Morning-
The Valeant Pharmaceuticals Inc. (NYSE: VRX) stock price soared some 16% to $110.98 Tuesday, but we remain bearish on the embattled drug maker in 2016.
You see, the company still faces a number of high hurdles.